Brazil IVD market: Zooming in on high-growth segments

As the largest in vitro diagnostic (IVD) market in Latin America (LATAM), Brazil is the gateway into leadership of the region’s market. 

While opportunities for exceptional growth can be found in each of the core IVD segments, two of them: point-of-care (POC) testing, and tissue diagnostics (TDx), will drive much of Brazil’s overall growth for the next few years.

With success in Brazil’s market important for maintaining one’s regional position and relevance in the LATAM market, we take a closer look at these fastest-growing core segments in this country where companies can invest in selectively.

Key insights:

  • Strong growth in age-related IVD test segments as the government strengthens emphasis on the role of preventive care through diagnostic and screening tests to manage burgeoning healthcare costs: EIU Healthcare anticipates some of the biggest growth potential in cardiac, cancer and diabetes related IVD test segments.
  • Increased adoption and use of digital pathology solutions in IVD laboratories to manage strain on healthcare resources: EIU Healthcare expects the annual growth rate of the digital pathology market in Japan over the next few years, to almost double that of the APAC region.

Download the report to find out:

  • Overall market size in 2018 and growth outlook (2018-2023) for Brazil’s IVD market  
  • Overall trend in four key IVD market segments – centralised diagnostics (CEDx), molecular diagnostics (MDx), point-of-care (POC) diagnostics, tissues diagnostics (TDx), and the top 3 fastest-growing sub-segments in each
  • Insights on fast-growing segments in POC diagnostics – infectious diseases and cardiac markers, with the spotlight on Zika virus testing
  • Impact of cancer care developments on TDx, with the spotlight on HER2 testing

For more data and insights on the surgical market, find out more about EIU Healthcare’s IVD Gateway.